Awareness of cognitive impairment in schizophrenia and its relationship to insight into illness

Schizophrenia Research

Volumn 133, Issue 1-3, 2011, Pages 187-192

  Gonzalez Suarez B ^a,b,d   Gomar, J J ^a,c,d   Pousa, E ^e   Ortiz Gil, J ^a,c,d   Garcia A ^a,d   Salvador, R ^a,c,d   Sans Sansa, B ^a,c   Pomarol Clotet, E ^a,c,d   McKenna, P J ^a,c,d  

^a Benito Menni CASM ^*  (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d FIDMAG GERMANES HOSPITALÀRIES RESEARCH FOUNDATION   (Spain)

^e Hospital Universitari Parc Taulí   (Spain)

Author keywords

Cognition; Insight; Neuropsychology; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; EXECUTIVE FUNCTION; FACTORIAL ANALYSIS; HUMAN; INTROSPECTION; MEMORY; MENTAL PATIENT; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGIST; RATING SCALE; SCALE TO ASSESS UNAWARENESS OF MENTAL DISORDER; SCHIZOPHRENIA; SCORING SYSTEM;

ADULT; AWARENESS; COGNITION DISORDERS; EXECUTIVE FUNCTION; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 81955160690     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.08.023     Document Type: Article

References (43)

1. Aleman A., Agrawal N., Morgan K.D., David A.S. Insight in psychosis and neuropsychological function: meta-analysis. Br. J. Psychiatry 2006, 189:204-212.
2. Insight and psychosis: awareness of illness in schizophrenia and related disorders 2004, Oxford University Press. 2nd edition. X.F. Amador, A.S. David (Eds.).
3. Amador X.F., Kronengold H. Understanding and assessing insight. Insight and Psychosis: Awareness of Illness in Schizophrenia and Related Disorders 2004, Oxford University Press. 2nd edition. X.F. Amador, A.S. David (Eds.).
4. Amador X.F., Strauss D.H. The scale to assess unawareness of mental disorder (SUMD) 1990, Coumbia University and New York State Psychiatric Institute.
5. Beck A.T., Baruch E., Balter J.M., Steer R.A., Warman D.M. A new instrument for measuring insight: the Beck Cognitive Insight Scale. Schizophr. Res. 2004, 68:319-329.
6. Benjamini Y., Yekutieli D. The control of the false discovery rate in multiple testing under dependency Ann. Statistics 2001, 29:1165-1188.
7. Chan R.C., Wang Y., Ma Z., Hong X.H., Yuan Y., Yu X., Li Z., Shum D., Gong Q.Y. Objective measures of prospective memory do not correlate with subjective complaints in schizophrenia. Schizophr. Res. 2008, 103:229-239.
8. David A.S. Insight and psychosis. Br. J. Psychiatry 1990, 156:798-808.
9. David A. The clinical importance of insight. Insight and Psychosis 1998, Oxford University Press. X.F. Amador, A. David (Eds.).
10. Del Ser T., Gonzalez-Montalvo J.I., Martinez-Espinosa S., Delgado-Villapalos C., Bermejo F. Estimation of premorbid intelligence in Spanish people with the Word Accentuation Test and its application to the diagnosis of dementia. Brain Cogn. 1997, 33:343-356.
11. Donohoe G., Hayden J., McGlade N., O'Grada C., Burke T., Barry S., Behan C., Dinan T.G., O'Callaghan E., Gill M., Corvin A.P. Is "clinical" insight the same as "cognitive" insight in schizophrenia?. J. Int. Neuropsychol. Soc. 2009, 15:471-475.
12. Farias S.T., Mungas D., Jagust W. Degree of discrepancy between self and other-reported everyday functioning by cognitive status: dementia, mild cognitive impairment, and healthy elders. Int. J. Geriatr. Psychiatry 2005, 20:827-834.
13. Gilleen J., Greenwood K., David A.S. Domains of awareness in schizophrenia. Schizophr. Bull. 2011, 37:61-72.
14. Gomar J.J., Ortiz-Gil J., McKenna P.J., Salvador R., Sans-Sansa B., Sarró S., Guerrero A., Pomarol-Clotet E. Validation of the Word Accentuation Test (TAP) as a means of estimating premorbid IQ in Spanish speakers. Schizophr. Res. 2011, 128:175-176.
15. Goverover Y., Chiaravalloti N., DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult. Scler. 2005, 11:203-212.
16. Grace J., Malloy P.F. Frontal systems behavior scale 2001, Psychological Assessment Resources, Inc.
17. Hart T., Whyte J., Polansky M., Millis S., Hammond F.M., Sherer M., Bushnik T., Hanks R., Kreutzer J. Concordance of patient and family report of neurobehavioral symptoms at 1year after traumatic brain injury. Arch. Phys. Med. Rehabil. 2003, 84:204-213.
18. Johnson I., Tabbane K., Dellagi L., Kebir O. Self-perceived cognitive functioning does not correlate with objective measures of cognition in schizophrenia. Compr. Psychiatry. 2011, 56:688-692.
19. Keefe R.S., Poe M., Walker T.M., Kang J.W., Harvey P.D. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am. J. Psychiatry 2006, 163:426-432.
20. Koren D., Seidman L.J., Poyurovsky M., Goldsmith M., Viksman P., Zichel S., Klein E. The neuropsychological basis of insight in first-episode schizophrenia: a pilot metacognitive study. Schizophr. Res. 2004, 70:195-202.
21. Koren D., Seidman L.J., Goldsmith M., Harvey P.D. Real-world cognitive- and metacognitive-dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff". Schizophr. Bull. 2006, 32:310-326.
22. Kremen W.S., Seidman L.J., Faraone S.V., Toomey R., Tsuang M.T. The paradox of normal neuropsychological function in schizophrenia. J. Abnorm. Psychol. 2000, 109:743-752.
23. Lysaker P.H., Carcione A., Dimaggio G., Johannesen J.K., Nicolò G., Procacci M., Semerari A. Metacognition amidst narratives of self and illness in schizophrenia: associations with neurocognition, symptoms, insight and quality of life. Acta Psychiatr. Scand. 2005, 112:64-71.
24. Lysaker P.H., Shea A.M., Buck K.D., Dimaggio G., Nicolò G., Procacci M., Salvatore G., Rand K.L. Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr. Scand. 2010, 122:405-413.
25. McEvoy J.P., Apperson L.J., Appelbaum P.S., Ortlip P., Brecosky J., Hammill K., Geller J.L., Roth L. Insight in schizophrenia. Its relationship to acute psychopathology. J. Nerv. Ment. Dis. 1989, 177:43-47.
26. Medalia A., Lim R.W. Self-awareness of cognitive functioning in schizophrenia. Schizophr. Res. 2004, 71:331-338.
27. Medalia A., Thysen J. Insight into neurocognitive dysfunction in schizophrenia. Schizophr. Bull. 2008, 34:1221-1230.
28. Medalia A., Thysen J. A comparison of insight into clinical symptoms versus insight into neuro-cognitive symptoms in schizophrenia. Schizophr. Res. 2010, 118:134-139.
29. Metacognition: Knowing About Knowing 1994, MIT Press. A.P. Shimamura, J. Metcalfe (Eds.).
30. Michon A., Deweer B., Pillon B., Agid Y., Dubois B. Relation of anosognosia to frontal lobe dysfunction in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1994, 57:805-809.
31. Moritz S., Ferahli S., Naber D. Memory and attention performance in psychiatric patients: lack of correspondence between clinician-rated and patient-rated functioning with neuropsychological test results. J. Int. Neuropsychol. Soc. 2004, 10:623-633.
32. O'Keeffe F.M., Murray B., Coen R.F., Dockree P.M., Bellgrove M.A., Garavan H., Lynch T., Robertson I.H. Loss of insight in frontotemporal dementia, corticobasal degeneration and progressive supranuclear palsy. Brain 2007, 130:753-764.
33. Ornstein T.J., Sahakian B.J., McKenna P.J. Memory and executive impairment in schizophrenia: comparison with frontal and temporal brain damage. Psychol. Med. 2008, 38:833-842.
34. Palmer B.W., Heaton R.K., Paulsen J.S., Kuck J., Braff D., Harris M.J., Zisook S., Jeste D.V. Is it possible to be schizophrenic yet neuropsychologically normal?. Neuropsychology 1997, 11:437-446.
35. Peralta V., Cuesta M.J. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia. Psychiatry Res. 1994, 53:31-40.
36. Piquard A., Derouesne C., Meininger V., Lacomblez L. DEX and executive dysfunction in activities of daily living in Alzheimer's disease and frontotemporal dementia. Psychol. Neuropsychiatr. Vieil. 2010, 8:215-224.
37. Ruiz A., Pousa E., Duno R., Crosas J., Cuppa S., Garcia C. Spanish adaptation of the Scale to Asses Unawareness of Mental Disorder (SUMD). Actas Esp. Psiquiatr. 2008, 36:111-1198.
38. Stip E., Caron J., Renaud S., Pampoulova T., Lecomte Y. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Compr. Psychiatry 2003, 44:331-340.
39. Sunderland A., Harris J.E., Baddeley A.D. Do laboratory tests predict everyday memory? A neuropsychological study. J. Verbal Learn. Verbal Behav. 1983, 22:341-357.
40. van den Bosch R.J., Rombouts R.P. Causal mechanisms of subjective cognitive dysfunction in schizophrenic and depressed patients. J. Nerv. Ment. Dis. 1998, 186:364-368.
41. Wilson B., Cockburn J., Baddeley A., Hiorns R. The Rivermead Behavioural Memory Test 1985, Thames Valley Test Company.
42. Wilson B., Cockburn J., Baddeley A., Hiorns R. The development and validation of a test battery for detecting and monitoring everyday memory problems. J. Clin. Exp. Neuropsychol. 1989, 11:855-870.
43. Wilson B.A., Burgess P.W., Emslie H., Evans J.J. Behavioural Assessment of the Dysexecutive Syndrome (BADS) 1996, Reading, UK.